HRYZ-T101 Injection for HPV18 Positive Solid Tumor | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
HRYZ-T101 Injection for HPV18 Positive Solid Tumor	Anal Cancer, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, anus disorder, anus neoplasm, carcinoma, cervix disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, head and neck squamous cell carcinoma, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile carcinoma, penile disorder, penile neoplasm, rectal disorder, rectal neoplasm, squamous cell carcinoma, uterine disorder, vaginal cancer, vaginal carcinoma, vaginal disorder, vulva cancer, vulvar carcinoma, vulvar disease	Recruiting	Phase 1	2024-02-02		NCT05952947

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
HRYZ Biotech Co.	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fudan University Shanghai Cancer Center	Shanghai	China	85